Tag Archives: European Union

EU Questions Electromagnetic Radiation Limits

By Peter ODonnell | Published: January 24, 2012
It is fashionable in many healthcare circles to denigrate the European Union for adopting a high-handed and inflexible approach to many of the complex issues that health policy is fated to cover. It is still more fashionable—indeed almost mandatory—to castigate the European Parliament, the EU’s self-styled representative of the people, for adopting an unrealistically cautious [...]
Posted in Regulatory | Also tagged , , , , | Leave a comment

Spending, But Wisely

By Peter ODonnell | Published: June 13, 2011
The European Union puts more than $10 billion a year into funding research—on top of what the 27 EU member states spend themselves, and of course in addition to the billions that industry invests in its own R&D. But it isn’t sure that it is getting value for money, so it is on the brink [...]
Posted in Uncategorized | Also tagged , , , | Leave a comment

Bringing People Together on Personalized Medicine

By Peter ODonnell | Published: May 6, 2011
Mid-May will see a further attempt by the European Union to bring some order to the chaos surrounding the future of personalized medicine. A major conference in Brussels will bring top-level speakers from across the continent together. There, they will take stock of recent achievements in health-related research leading to personalized medicine—and, still more ambitiously, [...]
Posted in Uncategorized | Also tagged , , , | Leave a comment

And Another New Initiative

By Peter ODonnell | Published: April 21, 2011
Criticism of European Union policy on medicines is easy—and often justified. But at least one EU project to foster the emergence of new medicines is attaining some success. The Innovative Medicines Initiative (IMI) is on the brink of issuing its fourth call for proposals, following the successful take-up of the earlier three calls.
Posted in Regulatory | Also tagged , , , , | Leave a comment

Bringing the Boys from Brazil On-Side

By Peter ODonnell | Published: March 9, 2011
It wasn’t to upgrade its skills in celebrating Mardi Gras that the European Medicines Agency invited regulators from Brazil to its very uncarnivalesque headquarters in London last week. But the outcome of the meeting will play a small role in keeping patients and trial subjects healthier and, hopefully, happier.
 The occasion was a three-day training course [...]
Posted in Regulatory | Also tagged , , , , , | Leave a comment